<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <atom:link rel="self" type="application/rss+xml" href="https://escholarship.org/uc/ucd_ome_posters_obgyn/rss"/>
    <ttl>720</ttl>
    <title>Recent ucd_ome_posters_obgyn items</title>
    <link>https://escholarship.org/uc/ucd_ome_posters_obgyn/rss</link>
    <description>Recent eScholarship items from Obstetrics and Gynecology</description>
    <pubDate>Sun, 21 Jun 2026 01:12:05 +0000</pubDate>
    <item>
      <title>Endometriosis Diagnosis &amp;amp; Treatment:Still a Surgical Process</title>
      <link>https://escholarship.org/uc/item/3s89p11b</link>
      <description>Endometriosis Diagnosis &amp;amp; Treatment:Still a Surgical Process</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3s89p11b</guid>
      <pubDate>Wed, 25 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Bloemhard, Miaoli</name>
      </author>
      <author>
        <name>Orozco, Deanna</name>
      </author>
      <author>
        <name>Prieto, Julian</name>
      </author>
      <author>
        <name>Paik, Clara</name>
      </author>
      <author>
        <name>Hou, Melody</name>
      </author>
    </item>
    <item>
      <title>A Characterization of Induction of Labor Practices in Primiparas at a Northern California Academic Tertiary Care Center</title>
      <link>https://escholarship.org/uc/item/026249nb</link>
      <description>Induction of labor (IOL) is the process by which medications or other methods are used to initiate labor in pregnant patients. Approximately 1 in 4 women in the United States are induced, up to 1 in 10 being induced for elective reasons. There are several approaches to IOL, which can vary based on the clinical context, the institution, as well as provider preference. It is unclear whether some methods or method combinations of IOL are of more benefit than others. At UC Davis, guidelines for approaching IOL are outlined but not completely standardized, leaving room for variabilities in practice, particularly in primipara patients (those giving birth for the first time).</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/026249nb</guid>
      <pubDate>Mon, 25 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Calderon, Alexandra</name>
      </author>
      <author>
        <name>Mitchell, Keyon</name>
      </author>
      <author>
        <name>Bates, Katherine</name>
      </author>
      <author>
        <name>Esparza, Caitlin</name>
      </author>
      <author>
        <name>Mo, Lihong</name>
      </author>
      <author>
        <name>Swanson, Debra</name>
      </author>
    </item>
    <item>
      <title>Completion of Postpartum Glucose Testing in Women with Gestational Diabetes witha 6-week vs 2- to 3-week Postpartum Visit: Preliminary Results</title>
      <link>https://escholarship.org/uc/item/0891x6wf</link>
      <description>&lt;p&gt;• About 2-10% of all pregnancies are affected by gestationaldiabetes mellitus (GDM)&lt;/p&gt;&lt;p&gt;• Women with GDM are 7x more likely to develop type 2 diabetes mellitus compared to those without GDM within 10years after delivery&lt;/p&gt;&lt;p&gt;• ADA and ACOG recommend glucose testing at 4-12 weeks after delivery to identify women with diabetes or impairedglucose metabolism&lt;/p&gt;&lt;p&gt;• Postpartum glucose screening rates in women with GDM remains strikingly low at 3.4%-38%&lt;/p&gt;&lt;p&gt;• Scheduling an earlier postpartum visit resulted in higher attendance rates; however, there is limited data on how anearlier postpartum visit may impact rates of postpartum glucose testing&lt;/p&gt;</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0891x6wf</guid>
      <pubDate>Mon, 4 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Mendoza, Yimdriuska M.</name>
      </author>
      <author>
        <name>Varshneya, Anindita</name>
      </author>
      <author>
        <name>Yam, Wendy</name>
      </author>
      <author>
        <name>Creinin, Mitchell D.</name>
      </author>
      <author>
        <name>Chen, Melissa J.</name>
      </author>
    </item>
    <item>
      <title>Comparison between the old and new MFMU TOLAC Calculator – Which is more accurate?</title>
      <link>https://escholarship.org/uc/item/95s9z4ms</link>
      <description>In 2017, the Maternal Fetal Medicine Units (MFMU) Network disseminated a Trial of Labor after Cesarean (TOLAC) calculator. An updated (2021) version of the calculator does not include race and ethnicity, but instead focuses on prior medical and OB history, in addition to age and BMI. The objective of this study was to compare the actual vs predicted VBAC rates between the old and new MFMU calculators.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/95s9z4ms</guid>
      <pubDate>Wed, 30 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Gunaseelan, Anita</name>
      </author>
      <author>
        <name>Cruz, Giovanna</name>
      </author>
      <author>
        <name>El-Sayed, Yasser Y</name>
      </author>
      <author>
        <name>Johnson, Christina</name>
      </author>
      <author>
        <name>Blumenfeld, Yair J</name>
      </author>
    </item>
    <item>
      <title>Pregnancy Outcomes in Women with Sickle Cell Disease in California: A Retrospective Cohort Study</title>
      <link>https://escholarship.org/uc/item/3rt8n5dp</link>
      <description>Pregnancy exacerbates sickle cell pathophysiology via: Increased metabolic and oxygen demands, State of hypercoagulability, Cardiopulmonary stress. Women with Sickle Cell Disease (SCD) have increased prevalence of peripartum complications like: Preeclampsia, Postpartum hemorrhage, Venous thromboembolism (VTE). Data on SCD and pregnancy outcomes are largely from single center studies with limited sample sizes. Aim to add to this limited body of literature by including SCD pregnancy data over 3 decades from the diverse state of California</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3rt8n5dp</guid>
      <pubDate>Tue, 29 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Fisch, Samantha C</name>
      </author>
      <author>
        <name>Brunson, Ann M</name>
      </author>
      <author>
        <name>Mahajan, Anjlee</name>
      </author>
      <author>
        <name>Keegan, Theresa HM</name>
      </author>
      <author>
        <name>Yu, Bo</name>
      </author>
      <author>
        <name>Wun, Ted</name>
      </author>
      <author>
        <name>Adesina, Oyebimpe O</name>
      </author>
    </item>
    <item>
      <title>The Impact of Magnetic Resonance (MR) Exposure on the Menses</title>
      <link>https://escholarship.org/uc/item/7bb9j91h</link>
      <description>Background: Magnetic resonance (MR) is a common imaging modality used in obstetrics and gynecology due its decreased radiation risk. MR risks specific to women have been studied, but mostly involve risks to a fetus in imaging done during pregnancy. In non-pregnant women, literature is limited to occupational survey evidence and case reports of abnormal uterine bleeding among female healthcare workers with frequent MR exposure and copper IUD use. Anecdotal reports from an online patient forum suggests a possible link with abnormal uterine bleeding after undergoing MR exposure. To our knowledge no formal research has been done to investigate abnormal uterine bleeding in association with MR exposure. This study aims to describe abnormal uterine bleeding, cramping/pelvic pain, or menstrual clotting after MR exposure in women who otherwise report regular menstrual cycles.​</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7bb9j91h</guid>
      <pubDate>Mon, 28 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Klimkiv, Liliya</name>
      </author>
      <author>
        <name>Fananapazir, Ghaneh</name>
      </author>
      <author>
        <name>Hou, Melody</name>
      </author>
    </item>
    <item>
      <title>Efficacy of Brexanolone in the Treatment of Post-Partum Depression</title>
      <link>https://escholarship.org/uc/item/6kb6k0w5</link>
      <description>&lt;p&gt;• Post-partum depression (PPD) affects 1 in 8 women&lt;/p&gt;&lt;p&gt;• PPD has consequences for both mother and child&lt;/p&gt;&lt;p&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;• Negatively impacts breastfeeding, sleep routines, well-child visits, vaccinations, and safety practices&lt;/p&gt;&lt;p&gt;• Until recently, the primary treatment for PPD has been psychotherapy and antidepressants&lt;/p&gt;&lt;p&gt;• Brexanolone (generic for Zulresso) was FDA approved March 2019 and is the first drug approved specifically for PPD&lt;/p&gt;&lt;p&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;• 60-hour IV infusion&lt;/p&gt;&lt;p&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;• Neurosteroid and analogue of allopregnanolone&lt;/p&gt;&lt;p&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;• This medication offers a novel approach to treatment of postpartum depression&lt;/p&gt;</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6kb6k0w5</guid>
      <pubDate>Mon, 28 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Bent, Rachel E.</name>
      </author>
      <author>
        <name>Hedriana, Herman L.</name>
      </author>
      <author>
        <name>Clark, Shannon</name>
      </author>
    </item>
    <item>
      <title>Pregnancy and Fertility trends among Female Otolaryngologists</title>
      <link>https://escholarship.org/uc/item/3wt926fg</link>
      <description>As the number of women entering the field of otolaryngology grows, so should discussions and awareness of the unique challenges that these women face with pregnancy, fertility and juggling their career and familial aspirations. We sought to determine childbearing patterns and decision making among female otolaryngologists and compare them to the general population.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3wt926fg</guid>
      <pubDate>Mon, 28 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Huguet, Makenzie</name>
      </author>
      <author>
        <name>Beliveau, Angela</name>
      </author>
      <author>
        <name>Taylor, Sandra</name>
      </author>
      <author>
        <name>Aizenberg, Debbie</name>
      </author>
    </item>
    <item>
      <title>Joint Epilepsy and Family Planning Clinic for Women with Epilepsy</title>
      <link>https://escholarship.org/uc/item/28c1m4xh</link>
      <description>&lt;p&gt;• Women with epilepsy (WWE) report higher rates of unintended pregnancy compared to the general US population&lt;/p&gt;&lt;p&gt;• Exposure to certain antiepileptic drugs (AEDs) can increase the risk of teratogenicity&lt;/p&gt;&lt;p&gt;• Only 25% of WWE consult their epileptologist regarding contraception&lt;/p&gt;&lt;p&gt;• An integrated epilepsy and family planning clinic may address the gynecologic needs of WWE&lt;/p&gt;</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/28c1m4xh</guid>
      <pubDate>Mon, 28 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Tsai, Rebecca</name>
      </author>
      <author>
        <name>Chen, Melissa J.</name>
      </author>
      <author>
        <name>Melo, Juliana</name>
      </author>
      <author>
        <name>Park, Katherine</name>
      </author>
      <author>
        <name>Kennedy, Jeffrey</name>
      </author>
    </item>
    <item>
      <title>Does Pregnancy Associated Melanoma have a Unique Microenvironment?</title>
      <link>https://escholarship.org/uc/item/1fq9t7mj</link>
      <description>Melanoma is one of the most common malignancy of both women of child-bearing age and during pregnancy. Modulations of the immune system that occur during pregnancy may play a role in the prognosis of melanoma in pregnancy (PAM).</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1fq9t7mj</guid>
      <pubDate>Mon, 28 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Kazmi, Maha</name>
      </author>
      <author>
        <name>Terrell, Jessica</name>
      </author>
      <author>
        <name>Li, Qian</name>
      </author>
      <author>
        <name>Zhu, Guannan</name>
      </author>
      <author>
        <name>Tartar, Danielle</name>
      </author>
      <author>
        <name>Keegan, Theresa</name>
      </author>
      <author>
        <name>Maverakis, Emanual</name>
      </author>
      <author>
        <name>Kiuru, Maija</name>
      </author>
    </item>
    <item>
      <title>Using Quantitative Blood Loss to Define Hemorrhage in Post-abortion Patients</title>
      <link>https://escholarship.org/uc/item/4rp00784</link>
      <description>Post-abortion hemorrhage occurs in about 1 in every 1000 patients and is highly associated with severe morbidities. Hemorrhage is defined variably across studies, including a range of amounts during a procedure (250 mL or 500 mL), an amount (1000 mL) within a 24- hour period, or specific outcomes such as hospitalization or blood transfusion. No standard hemorrhage “definition” has been elucidated, primarily due to the lack of any studies investigating the correlation of blood loss to clinically relevant outcomes. A clear definition would help standardize future research on procedural morbidity as well as interventions to decrease significant blood loss. This study aims to identify a quantitative blood loss during dilation and evacuation (D&amp;amp;E) procedures that correlates with clinically relevant outcomes to allow a clearer definition of “hemorrhage” as a procedural complication. We hypothesized that there will be a correlation between of quantitative blood loss (QBL) and the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4rp00784</guid>
      <pubDate>Tue, 22 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Gilbert, Cassandra</name>
      </author>
      <author>
        <name>Matulich, Melissa</name>
      </author>
      <author>
        <name>Creinin, Mitchell</name>
      </author>
    </item>
    <item>
      <title>Screening for Sex Trafficking in Labor and Delivery A Guideline-Based Approach</title>
      <link>https://escholarship.org/uc/item/8d41951t</link>
      <description>Human trafficking is defined as the recruitment and movement of individuals—most often by force, coercion, or deception—for the purpose of exploitation. It is important to clarify that trafficking does not have to be movement across international or state borders and it is not consensual commercial sex work. Human trafficking is a global public health epidemic with an estimated 40 million people trafficked worldwide in 2018. This $150 billion dollar industry places it as the second largest criminal enterprise. More than 49,000 case of human trafficking have been reported to the National Trafficking Hotline in the United States.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8d41951t</guid>
      <pubDate>Mon, 21 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Venturino, Madeline</name>
      </author>
      <author>
        <name>Timbang, Leah</name>
      </author>
      <author>
        <name>Wright, Debra</name>
      </author>
      <author>
        <name>Janke, Julie</name>
      </author>
    </item>
    <item>
      <title>Racial/Ethnic Differences in the Use of Long-Acting Contraception Among Low-Income Californian Women</title>
      <link>https://escholarship.org/uc/item/1t89g6dq</link>
      <description>Up to 25% of US women regret having undergone surgical sterilization. Intrauterine contraception (IUC) can be safely used for up to 20 years offering rapidly-reversible contraception that is as effective as surgical sterilization. FamilyPACT covers service for Californians living at or below 200% of the Federal Poverty Level, who do not meet criteria for Medi-Cal eligibility. Discriminatory medical practices have long-term effects on minority communities’ trust in the healthcare system. California has a problematic history of eugenics practices that spanned over 70 years, until 2010.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1t89g6dq</guid>
      <pubDate>Fri, 11 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Calderon, Alexandra</name>
      </author>
      <author>
        <name>Padovani, Andrew</name>
      </author>
      <author>
        <name>Canfield, Rebecca</name>
      </author>
      <author>
        <name>Campa, Olivia</name>
      </author>
      <author>
        <name>Bimla Schwarz, Eleanor</name>
      </author>
    </item>
    <item>
      <title>Outcomes of 8-Hour Observation for Dilation and Evacuation at 22 Weeks or Greater</title>
      <link>https://escholarship.org/uc/item/5rr3567x</link>
      <description>&lt;p&gt;Second trimester abortion is associated with higherrates of complications compared to first trimesterabortion. Common complications for second trimester abortioninclude uterine perforation, uterine rupture andhemorrhage.&lt;/p&gt;&lt;p&gt;Standardized interventions for second trimestermedical terminations have not decreased rates ofpostoperative dilation and curettage (D&amp;amp;C) or othercomplications.&lt;/p&gt;&lt;p&gt;Little is known about the frequency or timing ofspecific complications during second trimestertermination of pregnancy.&lt;/p&gt;&lt;p&gt;Current standardized intervention at UC Davis fortermination of pregnancies 22 weeks gestational ageor more requires patients to be observed in the post-anesthesia care unit (PACU) for 8 hours post-operation.&lt;/p&gt;&lt;p&gt;This project aims to evaluate the timing and rates ofcomplications to determine the effectiveness as well aspossible revisions that can be made to the institutionalpostoperative monitoring after dilation and evacuationat 22 weeks gestational age (GA)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5rr3567x</guid>
      <pubDate>Thu, 29 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Green, Xochitl</name>
      </author>
      <author>
        <name>Hou, Melody Y</name>
      </author>
    </item>
    <item>
      <title>Outcomes and risk of complications for patients undergoing dilation and evacuation for intrauterine fetal demise</title>
      <link>https://escholarship.org/uc/item/2qc7n2ws</link>
      <description>&lt;p&gt;Dilation and evacuation (D&amp;amp;E) is safer and more effective than labor induction for uterine evacuation of patients withsecond-trimester intrauterine fetal demise (IUFD). Patients with IUFD are at higher risk of complications, including hemorrhage and disseminated intravascularcoagulation (DIC), compared to patients undergoing D&amp;amp;E for other indications.&lt;/p&gt;&lt;p&gt;We aimed to describe outcomes, rates of complications, and associated risk factors for patients undergoing D&amp;amp;E for IUFD at our institution.&lt;/p&gt;</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2qc7n2ws</guid>
      <pubDate>Thu, 29 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Potter, Laura A</name>
      </author>
      <author>
        <name>Ly, Serena H</name>
      </author>
      <author>
        <name>Pei, Xiaohe</name>
      </author>
      <author>
        <name>Hou, Melody Y</name>
      </author>
    </item>
    <item>
      <title>Adverse Outcomes of Second Trimester Dilation and Evacuation in Patients with Prior Cesarean Delivery</title>
      <link>https://escholarship.org/uc/item/9s65f8h6</link>
      <description>Prior Cesarean delivery (CD) has beenshown to increase the overall complication risk in second trimester dilation and evacuation (D&amp;amp;E) procedures; however, little data existsabout frequency of specific risks. The objective is to determine the proportion of patients with prior CD that experienced adverse outcomes associated with D&amp;amp;Eprocedures.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9s65f8h6</guid>
      <pubDate>Wed, 28 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Coley, Masani</name>
      </author>
      <author>
        <name>Meadows, Kayla G</name>
      </author>
      <author>
        <name>Hou, Melody Y</name>
      </author>
      <author>
        <name>Chen, Melissa J</name>
      </author>
    </item>
    <item>
      <title>Placental mass in association with neonatal mosaic trisomy 21: genetic makeup consistent with acardiac amorphous twin</title>
      <link>https://escholarship.org/uc/item/8hs88521</link>
      <description>Placental teratomas thought to arisefrom germ cells migrating into extraplacental membranes. Historically, placental teratomas were differentiated from acardiac amorphoustwins by presence of multiple tissuetypes, but lack of axial organization andumbilical cord. New evidence - previously documented placental teratomas may insteadrepresent acardiac amorphous twin given similar pattern of short tandem repeat (STR) polymorphic loci between placental masses (thought to be teratoma) and adjacent normalplacental tissue.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8hs88521</guid>
      <pubDate>Wed, 28 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Weiss, M</name>
      </author>
      <author>
        <name>Chithiwala, Z</name>
      </author>
      <author>
        <name>Karnezia, A</name>
      </author>
      <author>
        <name>Chien, J</name>
      </author>
      <author>
        <name>Hedriana, H</name>
      </author>
      <author>
        <name>Singh, K</name>
      </author>
    </item>
    <item>
      <title>Developing a Pathway for URM Students: Are We Helping?</title>
      <link>https://escholarship.org/uc/item/8cx4t1dd</link>
      <description>The UCSF/Kaiser Permanente UndergraduateResearch Internship (URI) is an eight-week pathway program aimed to support underrepresented minority (URM) students through opportunities for clinical shadowing, research, and mentorship.Our objective is to study the impact of URI onparticipants’ self-efficacy and professionaloutcomes.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8cx4t1dd</guid>
      <pubDate>Wed, 28 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Guevarra, Oliver A</name>
      </author>
      <author>
        <name>Lager, Jennette</name>
      </author>
    </item>
    <item>
      <title>Abortion Care in the Context of Changing Legislation: Amplifying Abortion-Trained Physician Experiences and Perspectives From California, Texas, Ireland, and the UK</title>
      <link>https://escholarship.org/uc/item/5309s5g6</link>
      <description>&lt;p&gt;The primary aim was to examining abortion-trained physician perspectives on barriers toabortion access and their views on physicians'roles in the legislative regulation of abortion.&lt;/p&gt;&lt;p&gt;The secondary aim was to elicit theperspectives and experiences of abortion-trained physicians to understand the effectsof legislation on their ability to providepatients with comprehensive reproductivecare.&lt;/p&gt;</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5309s5g6</guid>
      <pubDate>Wed, 28 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Allaert, Emilie</name>
      </author>
      <author>
        <name>Liu, Caroline</name>
      </author>
      <author>
        <name>Liu, Katherine</name>
      </author>
      <author>
        <name>Truong, Anna</name>
      </author>
      <author>
        <name>Wilkes, Michael</name>
      </author>
    </item>
    <item>
      <title>Consistency in Contraception Choice through 6 Months Postpartum</title>
      <link>https://escholarship.org/uc/item/25x5529w</link>
      <description>To evaluate the consistency of contraceptionplan identified at delivery hospitalization withreported contraception use over 6 monthspostpartum.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/25x5529w</guid>
      <pubDate>Wed, 28 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Chan, Connie</name>
      </author>
      <author>
        <name>Hoch, Jeffrey S</name>
      </author>
      <author>
        <name>Chen, Melissa J</name>
      </author>
    </item>
    <item>
      <title>Improving Utilization and Quality of Survivorship Care for Patients with Gynecological Malignancies</title>
      <link>https://escholarship.org/uc/item/2g3527vn</link>
      <description>&lt;p&gt;After patients end their cancer treatmentand have no evidence of disease, theyenter survivorship portion of their care.&lt;/p&gt;&lt;p&gt;Survivorship programs provide thefollowing services: psychosocial support,nutrition, medication side-effects, geneticcounseling, and fertility concerns throughthe use of treatment summaries andsurvivorship care plans. Patients continue to face difficulty in accessing services.&lt;/p&gt;&lt;p&gt;Objectives: To increase enrollment insurvivorship program.&lt;/p&gt;</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2g3527vn</guid>
      <pubDate>Tue, 27 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Gill, Sonia</name>
      </author>
      <author>
        <name>Rubin, Nicole</name>
      </author>
      <author>
        <name>Ruskin, Rachel</name>
      </author>
    </item>
    <item>
      <title>Case Report: Novel Uterine Tumor Resembling Ovarian Sex Cord Tumors-Like Lesion</title>
      <link>https://escholarship.org/uc/item/9bh7p3k0</link>
      <description>Case Report: Novel Uterine Tumor Resembling Ovarian Sex Cord Tumors-Like Lesion</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9bh7p3k0</guid>
      <pubDate>Fri, 23 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Abbasi, Ferheen</name>
      </author>
      <author>
        <name>Nucci, Marisa</name>
      </author>
      <author>
        <name>Fletcher, Christopher</name>
      </author>
      <author>
        <name>Doron, Ben</name>
      </author>
      <author>
        <name>Watkins, Jaclyn</name>
      </author>
      <author>
        <name>Chien, Jeremy</name>
      </author>
      <author>
        <name>Karnezis, Anthony</name>
      </author>
    </item>
    <item>
      <title>Pregnancy Remembrace Optons and Impact or Coping Ability After Abortion</title>
      <link>https://escholarship.org/uc/item/6h08t2q6</link>
      <description>Pregnancy Remembrace Optons and Impact or Coping Ability After Abortion</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6h08t2q6</guid>
      <pubDate>Fri, 23 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Burgos, Maria</name>
      </author>
      <author>
        <name>Arroyo-Velazquez, Yakelin</name>
      </author>
      <author>
        <name>Nguyen, Hanh</name>
      </author>
      <author>
        <name>Oko, Obinna</name>
      </author>
      <author>
        <name>Schmidt, Ashley</name>
      </author>
      <author>
        <name>Creinin, Mitchell</name>
      </author>
      <author>
        <name>Wilson, Susan</name>
      </author>
      <author>
        <name>Hou, Melody</name>
      </author>
    </item>
    <item>
      <title>Demographics of U.S. Medical Students retaining, gaining, or losing interest in OB-GYN</title>
      <link>https://escholarship.org/uc/item/3x97v4fb</link>
      <description>To describe the race and ethnicity, gender, and financial status of students who remain interested in (retention), become interested in (recruitment), or lose interest in (attrition) OBGYN from matriculation to graduation.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3x97v4fb</guid>
      <pubDate>Fri, 23 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Guzman Perez, Diana</name>
      </author>
      <author>
        <name>Ponzini, Matthew</name>
      </author>
      <author>
        <name>Wilson, Machelle</name>
      </author>
      <author>
        <name>Hou, Melody</name>
      </author>
    </item>
    <item>
      <title>“I work with what I have”: Managing Medication Abortion and&amp;nbsp;Miscarriage in the Unhoused Community</title>
      <link>https://escholarship.org/uc/item/0fw2f7zx</link>
      <description>To provide better support to houseless individuals’experiences with MAB.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0fw2f7zx</guid>
      <pubDate>Fri, 23 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Adams, Lindsay</name>
      </author>
      <author>
        <name>Karlin, Jennifer</name>
      </author>
    </item>
  </channel>
</rss>
